JLE

European Journal of Dermatology

MENU

Metabolic syndrome and comorbidities in patients with psoriasis: a community-based case-control study from the Nagahama cohort in Japan Volume 32, numéro 1, January-February 2022

Illustrations


  • Figure 1.

  • Figure 2.

Tableaux

Auteurs
On behalf of the Nagahama Study group
1 Department of Dermatology, Kyoto University, Kyoto, Japan
2 St John’s Institute of Dermatology, School of Basic and Medical Biosciences, King’s College London, London, UK
3 Center for Genomic Medicine, Kyoto University, Kyoto, Japan
* Reprints

The aetiological relationship between psoriasis and systemic comorbidities has been at the centre of academic interest [1]. Psoriasis is an inflammatory skin disease that induces plaques with scaling erythema. The prevalence of psoriasis is approximately 0.43% in Japan and the number of patients with psoriasis is reportedly increasing [2, 3]. Psoriasis affects the skin but deleteriously impacts on the overall health of patients. The first study on systemic complications of psoriasis described an [...]